Elixinol Wellness Limited
ELLXF
$0.01
$0.0092.50%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -334.46% | -327.31% | -9.10% | -7.05% | 125.15% |
| Total Depreciation and Amortization | -28.57% | -30.79% | -7.46% | -9.23% | 51.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -340.96% | -333.73% | 1,473.77% | 1,447.74% | 167.10% |
| Change in Net Operating Assets | 124.60% | 123.85% | -- | -- | -256.84% |
| Cash from Operations | -39.29% | -35.03% | 37.32% | 38.49% | 38.25% |
| Capital Expenditure | -248.98% | -240.00% | 71.62% | 72.30% | -36.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 74.98% | 75.73% | -- | -- | -345.21% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.72% | -100.71% | 100.00% |
| Cash from Investing | 61.47% | 62.65% | -106.94% | -106.81% | -433.00% |
| Total Debt Issued | -75.84% | -75.84% | -- | -- | 187.00% |
| Total Debt Repaid | 75.83% | 75.83% | 44.77% | 44.77% | -120.00% |
| Issuance of Common Stock | 69.77% | 69.77% | -95.26% | -95.26% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -93.49% | -93.49% | 96.96% | 96.96% | -- |
| Cash from Financing | 68.82% | 63.63% | -46.06% | -47.07% | 1,485.16% |
| Foreign Exchange rate Adjustments | 1,900.00% | 1,891.30% | -510.00% | -500.00% | -43.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 164.21% | 162.20% | -98.99% | -99.02% | 78.63% |